Cancer BiologybioRxivPreprint
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystals
M. H. Jones, N. E. Quispe Calla, R. Smith…·J. D. Best
This study demonstrates that PODS-IL-2, a phagocytic-competent protein co-crystal, can deliver low-dose IL-2 effectively for treating melanoma and renal cell carcinoma with improved tolerability.
DOI 10.1101/2023.04.06.534711